Dong et al. found that the protective impact of valproate in decreasing anxiety, cognitive dysfunction, and symptoms of BD is linked to elevated expression levels of reelin (RELN) gene and glutamic acid decarboxylase 67 (Gad-67) via decreasing DNAm of their promoters in nuclear extracts from the brain of adult mice [77]. This evidence concerns the gene RELN and Anxiety.